Abstract:β-Glucuronidase is a lysosomal enzyme and a molecular model of a class of therapeutics approved as enzyme replacement therapies for lysosomal storage diseases. Understanding the effect of bioreactor process variables on the production and quality of the biologics is critical for maintaining quality and efficacy of the biotherapeutics. Here, we have investigated the effect of three process variables, in a head-to-head comparison using a parallel bioreactor system (<em>n</em> = 8), namely 0.25 mM butyrate addition, a temperature shift (from 37 to 32 °C), and a pH shift (from 7.0 to 6.7) along with a control (pH 7, temperature 37 °C, and no additive) on the production and quality of human recombinant β-glucuronidase (GUS) by a Chinese hamster ovary (CHO) cell line. The study was performed as two independent runs (2 bioreactors per treatment per run; <em>n</em> ≤ 4). Although statistically not significant, protein production slightly increased with either 0.25 mM butyrate addition (13%) or pH shift (7%), whereas temperature shift decreased production (12%, not significant). Further characterization of the purified GUS samples showed that purification selectively enriched the mannose-6-phosphate (M6P)–containing GUS protein. Noticeably, a variation observed for the critical quality attribute (CQA) of the enzyme, namely M6P content, decreased after purification, across treatment replicates and, more so, across different treatments. The dimer content in the purified samples was comparable (~25%), and no significant discrepancy was observed in terms of GUS charge variants by capillary electrophoresis analysis. MALDI-TOF/TOF analysis of released N-glycans from GUS showed a minor variation in glycoforms among the treatment groups. Temperature shift resulted in a slightly increased sialylated glycan content (21.6%) when compared to control (15.5%). These results suggest that bioreactor processes have a differential effect, and better control is required for achieving improved production of GUS enzyme in CHO cells without affecting drastically its CQAs. However, the purification method allowed for enrichment of GUS with similar CQA profiles, regardless of the upstream treatments, indicating for the first time that the effect of slight alterations in upstream process parameters on the CQA profile can be offset with an effective and robust purification method downstream to maintain drug substance uniformity.

Maximization of uricase production in a column bioreactor through RSM based optimization

Optimization of Culture Conditions for Production of Cis-Epoxysuccinic Acid Hydrolase Using Response Surface Methodology

Optimization of bacteriocin production by a new Lactobacillus strain, ZJ317, using response surface methodology

Improvement of uricase production from Bacillus subtilis RNZ-79 by solid state fermentation of shrimp shell wastes

Microbial Uricase and its Unique Potential Applications

Recombinant Expression and Functional Assessment of Uricase from a Pertinent Origin of the Enzyme, Streptomyces sp. Strain 17-1

Development of a continuous fermentation process for the production of recombinant uricase enzyme by Pichia pastoris

Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology

Medium Optimization for High Yield Production of Human Serum Albumin in Pichia Pastoris and Its Efficient Purification

Use of response surface methodology for optimizing process parameters for high inulinase production by the marine yeast Cryptococcus aureus G7a in solid-state fermentation and hydrolysis of inulin

Scale-up fermentation of Escherichia coli for the production of recombinant endoglucanase from Clostridium thermocellum

Optimization of Fermentation Conditions for Recombinant Human Interferon Beta Production by Escherichia coli Using the Response Surface Methodology

Statistical Optimization of Alkaline Protease Enzyme Produced by Bacillus subtilis MH266414 and its Application in Different Industries

Integrated Bioprocess for the Production and Isolation of Urokinase from Animal Cell Culture Using Supermacroporous Cryogel Matrices

Medium Optimization for Submerged Fermentative Production of β‐Cyclodextrin Glucosyltransferase by Isolated Novel Alkalihalophilic Bacillus sp. NCIM 5799 Using Statistical Approach

Optimization of Culture Conditions of Immobilized Cells for Enzyme Excretion and Cell Lysis

Optimization of protein production by Micrococcus luteus for exploring pollutant-degrading uncultured bacteria

Streptomyces griseorubens as a microbial cell factory for extracellular uricase production and bioprocess optimization using statistical approach

Differential effects of bioreactor process variables and purification on the human recombinant lysosomal enzyme β-glucuronidase produced from Chinese hamster ovary cells

Application of Plackett Burman and Box Behnken Design for the Optimization of a-glucosidase Production by Thermophillic Thermomyces dupontii